Nonacus
Michael Parks has a strong background in cancer biology, genetics, and molecular biology. With experience in various research institutions and universities, Michael has worked on projects related to non-invasive prenatal diagnosis, single gene disorders, cancer studies, and infectious diseases. Currently, Michael serves as the Head of Research and Development at Nonacus Ltd, where Michael is involved in designing innovative diagnostic solutions for prenatal healthcare and oncology.
This person is not in any teams
Nonacus
Nonacus is focused on delivering innovative technologies to the genomic healthcare sector through the use of cell free circulating DNA as a non-invasive diagnostic tool. Nonacus was created by a team of highly motivated scientists and sector professionals with experience in translating research into routine diagnostic tools that benefit patients. Nonacus provides end to end validated solutions for the use of cell free DNA in genetic testing. Established in 2015 and located at the Birmingham BioHub UK we have been actively perfecting and refining our processes for use in healthcare diagnostics.